Literature DB >> 8138023

Ascorbic acid inhibits protein tyrosine phosphatases in NIH 3T3 cells expressing human epidermal growth factor receptors.

H P Monteiro1, Y Ivaschenko, R Fischer, A Stern.   

Abstract

1. Physiological concentrations of ascorbic acid inhibited PTPase activity in HER 14 cells. 2. Higher concentrations of ascorbic acid produced a weaker inhibitory effect on PTPase activity in HER 14 cells. 3. EGF prevented the inhibitory effect of ascorbic acid on PTPase activity in HER 14 cells. 4. The inhibitory effect of physiological concentrations of ascorbic acid on PTPase activity depends on density of the cell culture, with less dense populations exhibiting greater inhibition of PTPase activity. 5. These observations suggest that ascorbic acid might have a modulatory role in cellular phosphorylation-dephosphorylation events.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8138023     DOI: 10.1016/0020-711x(88)90317-5

Source DB:  PubMed          Journal:  Int J Biochem        ISSN: 0020-711X


  2 in total

1.  The enhanced tumor inhibitory effects of gefitinib and L-ascorbic acid combination therapy in non-small cell lung cancer cells.

Authors:  Kyoung Eun Lee; Eunsil Hahm; Seyeon Bae; Jae Seung Kang; Wang Jae Lee
Journal:  Oncol Lett       Date:  2017-05-02       Impact factor: 2.967

2.  Nitric oxide stimulates tyrosine phosphorylation in murine fibroblasts in the absence and presence of epidermal growth factor.

Authors:  T M Peranovich; A M da Silva; D M Fries; A Stern; H P Monteiro
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.